Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
Abstract Objective To explore the role and possible regulatory mechanisms of CYP2E1 in gliomas. Methods RNA‑seq data and corresponding clinical information of glioma patients were collected from The Cancer Genome Atlas and Chinese Glioma Genome Atlas, and mRNA data of normal brain tissues were obtai...
Guardado en:
Autores principales: | Liguo Ye, Yang Xu, Long Wang, Chunyu Zhang, Ping Hu, Shi’ao Tong, Zhennan Liu, Daofeng Tian |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a59936b77e14d3ea75c21db495b1d2d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Yang Xu, et al.
Publicado: (2021) -
New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Liwei Zhou, et al.
Publicado: (2021) -
Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
por: Kata W. Pedersen, et al.
Publicado: (2021) -
Downregulation of STOX1 is a novel prognostic biomarker for glioma patients
por: Jin Fei-qin, et al.
Publicado: (2021) -
Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma
por: Junsheng Zhao, et al.
Publicado: (2021)